Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38832
Título : COVID-19 in Colombia endpoints. Are we different, like Europe?
Autor : Amariles Muñoz, Pedro
Ceballos Rueda, Javier Mauricio
Granados Vega, Elkyn Johan
Montoya Guarín, Carlos Julio
metadata.dc.subject.*: COVID-19
Colombia - epidemiología
Colombia - epidemiology
Atención a la Salud - organización & administración
Delivery of Health Care - organization & administration
Europa (Continente) - epidemiología
Europe - epidemiology
Humanos
Humans
Factores de Riesgo
Risk Factors
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D005060
https://id.nlm.nih.gov/mesh/D006801
https://id.nlm.nih.gov/mesh/D012307
Fecha de publicación : 2021
Editorial : Elsevier
Citación : Amariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013.
Resumen : ABSTRACT: The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.
metadata.dc.identifier.eissn: 1934-8150
ISSN : 1551-7411
metadata.dc.identifier.doi: 10.1016/j.sapharm.2020.03.013
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdfArtículo de investigación1.88 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons